定制开窗/分支腔内移植物等待期内动脉瘤破裂与靶内脏血管闭塞风险
本研究前瞻性收集2008至2017年141例计划行定制开窗/分支腔内修复的肾旁/肾周腹主动脉瘤及胸腹主动脉瘤患者,回顾分析133例完整数据。平均等待期89天,5例(3.8%)发生动脉瘤破裂,12个(3%)靶内脏血管闭塞。动脉瘤直径>70 mm为破裂独立危险因素,靶血管术前重度狭窄为闭塞危险因素。
要点
- 定制开窗/分支腔内移植物平均等待期89天,期间动脉瘤破裂风险3.8%。
- 动脉瘤直径>70 mm是等待期破裂的独立危险因素。
- 靶内脏血管术前重度狭窄者等待期闭塞风险增加。
核心结论
- 定制开窗/分支腔内修复平均等待期89天,等待期内动脉瘤>70 mm者破裂风险高,严重狭窄的靶内脏血管闭塞风险高。
- 这些因素应在定制开窗/分支腔内移植物修复的适应证选择中加以考虑。
研究设计与样本
- 前瞻性收集2008至2017年计划行定制开窗/分支腔内移植物的患者,回顾性分析解剖、手术及术后数据。
- 共141例计划修复,133例(男性87%,年龄73±6岁)数据完整纳入分析;肾旁/肾周腹主动脉瘤75例(56%),胸腹主动脉瘤58例(44%)。
主要发现
- 平均动脉瘤直径58±6 mm(肾旁/肾周腹主动脉瘤56±6 mm,胸腹主动脉瘤67±8 mm),15例(11%)直径>70 mm。
- 平均等待期89±25天,5例(3.8%)发生动脉瘤破裂(肾旁/肾周腹主动脉瘤1例,胸腹主动脉瘤4例),其中2例(1.5%)发生在制造期间,3例(2.3%)发生在移植物已到医院时(均因心脏或肺部合并症推迟手术)。
- 5例破裂中4例直径>70 mm;单因素分析慢性阻塞性肺疾病(P=.01;OR 2.6;95%CI 2.1-3.2)和动脉瘤直径>70 mm(P=.001;OR 42;95%CI 4-411)为破裂危险因素,多因素分析直径>70 mm为独立危险因素(P=.005;OR 29.3;95%CI 2.8-308)。
- 共8例(6%)移植物未植入(拒绝2例、动脉瘤破裂4例、非动脉瘤相关死亡2例);剩余125例(94%)计划405个靶内脏血管,术前CT血管造影示46个(11%)重度狭窄。
- 等待期内12个(3%)靶内脏血管闭塞(肾动脉5个、腹腔干7个),6个再通、6个放弃;术前重度狭窄为靶内脏血管闭塞危险因素(P=.000;OR 1.3;95%CI 1.1-1.6)。
临床怎么用
- 对直径>70 mm的动脉瘤患者,选择定制开窗/分支腔内修复时应充分评估等待期破裂风险,考虑替代方案或加快移植物获取。
- 对靶内脏血管术前重度狭窄(>75%开口管腔)者,应警惕等待期闭塞风险,制定监测或干预策略。
局限性
- 研究为单中心回顾性分析,样本量有限(133例),结论外推需谨慎。
- 等待期定义涵盖制造时间与临床原因,未区分二者对不良事件的独立影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate adverse events occurring during the lead period of custom-made fenestrated/branched endograft for juxtarenal/pararenal abdominal aortic aneurysm (j/p-AAA) and thoracoabdominal aortic aneurysm (TAAA). METHODS: Between 2008 and 2017, patients enrolled for custom-made fenestrated/branched endograft repair were prospectively collected. Anatomic, procedural, and postoperative data were retrospectively analyzed. Lead period was defined as the time between the endograft order to the manufacturer and implantation. Aneurysm diameter, target visceral vessel (TVV) severe stenosis (>75% of ostial lumen), and number of planned TVVs were evaluated at preoperative computed tomography angiography. Patency of TVVs was evaluated intraoperatively. Aneurysm rupture and TVV occlusion during the lead period were assessed. RESULTS: There were 141 custom-made fenestrated/branched endograft repairs planned. Of these, 133 patients (male, 87%; age, 73 ± 6 years) with complete available data were considered for the study. There were 75 (56%) j/p-AAAs and 58 (44%) TAAAs. The mean aneurysm diameter was 58 ± 6 mm (j/p-AAA, 56 ± 6 mm; TAAA, 67 ± 8 mm); 15 cases (11%) had >70-mm diameter. Planned TVVs were 431 (mean, 3 ± 1 TVVs/patient). The mean lead period was 89 ± 25 days, with five (3.8%) aneurysm ruptures (j/p-AAA, one; TAAA, four) occurring, two (1.5%) during manufacture and three (2.3%) with endograft available in the hospital (all three procedures were postponed because of cardiac or pulmonary comorbidities). In one TAAA rupture, the endograft was successfully implanted and the patient survived. Four of five ruptures had >70-mm diameter. On univariate analysis, chronic obstructive pulmonary disease (P = .01; odds ratio [OR], 2.6; 95% confidence interval [CI], 2.1-3.2) and aneurysm diameter >70 mm (P = .001; OR, 42; 95% CI, 4-411) were risk factors for aneurysm rupture during the lead period, with aneurysm diameter >70 mm being confirmed as an independent risk factor on multivariate analysis (P = .005; OR, 29.3; 95% CI, 2.8-308). Overall, eight endografts (6%) were not implanted (refusal, two; aneurysm rupture, four; death not related to aneurysm, two). In the remaining 125 patients (94%), 405 TVVs were planned. Of them, 46 (11%) had severe stenosis at preoperative computed tomography angiography. Twelve (3%) TVVs occluded in the lead period (renal arteries, five; celiac trunks, seven); six were recanalized and six were abandoned. Severe preoperative stenosis was a risk factor for TVV occlusion during the lead period (P = .000; OR, 1.3; 95% CI, 1.1-1.6). CONCLUSIONS: In our series, custom-made design required a mean lead period of 89 days, which was determined by both manufacturing time and clinical reasons. During this delay, there is a high risk of both rupture in aneurysms >70 mm and TVV occlusion in severely stenosed vessels. These factors should be considered in the indication for custom-made fenestrated/branched endograft repair.
引用
- Gallitto E, Faggioli G, Spath P, et al. The risk of aneurysm rupture and target visceral vessel occlusion during the lead period of custom-made fenestrated/branched endograft. J Vasc Surg. 2020. PMID: 32063442. doi:10.1016/j.jvs.2019.08.273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。